Biomarker Immunological screening Covid-19

Biomarker Immunological Screening on Covid-19 samples up to 400 different markers testing menu on multiplex platform able up to 65 analyte on the same sample.


Multiplex quantification of inflammatory Cytokine release syndrome (CRS), also known as cytokine storm syndrome, has recently been described in association with COVID-19 in the Lancet published on March 16, 2020.

Multiplex quantification in a single experiment is the way to go to study the numerous cytokines and chemokines commonly linked to CRS.

A dedicated protocol has been optimized for the screening of the Covid-19 samples.
100uL of samples may generate up to 100 different biomarker analysis:

Human Combo 65 Plex

APRIL, BAFF, BLC, CD30, CD40L, ENA-78, Eotaxin, Eotaxin-2, Eotaxin-3, FGF-2, Fractalkine, G-CSF, GM-CSF, Gro a, HGF, IFN-a, IFN-g, IL-10, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IL-18, IL-1a,IL-1b, IL-2, IL-20, IL-21, IL-22, IL-23, IL-27, IL-2R, IL-3, IL-31, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IP-10, I-TAC, LIF, MCP-1, MCP-2, MCP-3, M-CSF, MDC, MIF, MIG, MIP1a, MIP-1b, MIP-3a, MMP-1,NGF beta, SCF, SDF-1a, TNF b, TNF-a, TNF-R2, TRAIL, TSLP, TWEAK, VEGF-A

Human XL Immuno 45 Plex

CD40 Ligand, EGF, IL-8, IL-10, Eotaxin, IL-12 p70, FGF basic, IL-13, Flt-3 Ligand, IL-15, Fractalkine, IL-17A, G-CSF, IL-17E, GM-CSF, IL-33, Granzyme B, IP-10, GROα, MCP-1, GROβ, MIP-1α, IFN-α, MIP-1β, IFN-β, MIP-3α, IFN-γ, MIP-3β, IL-1α, PDGF-AA, IL-1β, PDGF-AB/BB, IL-1ra, PD-L1/B7-H1, IL-2, RANTES, IL-3, TGF-α, IL-4, TNF-α, IL-5, TRAIL, IL-6, VEGF, IL-7

Human Th1/Th2 Cytokine 11 Plex

GM-CSF, IFNγ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-12 p70, IL-13, IL-18, TNFα

Custom panels available